Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Clinical Pharmacology and Therapeutics|October 23, 1997
Optimizing levodopa pharmacokinetics with multiple tolcapone doses in the elderlyK M Jorga, G Sedek, B Fotteler, et al.European Journal of Clinical Pharmacology|January 1, 1996
Multiple-dose clinical pharmacology of the catechol-O-methyl-transferase inhibitor tolcapone in elderly subjectsJ Dingemanse, K Jorga, G Zürcher, et al.European Journal of Neurology|March 4, 1999
The effect of tolcapone on the pharmacokinetics of benserazideK M Jorga, J P Larsen, A Beiske, et al.Clinical Pharmacology and Therapeutics|July 15, 1998
Effect of liver impairment on the pharmacokinetics of tolcapone and its metabolitesK M Jorga, J M Kroodsma, B Fotteler, et al.Clinical Pharmacology and Therapeutics|May 1, 1995
Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humansJ Dingemanse, K M Jorga, M Schmitt, et al.Clinical Neuropharmacology|May 10, 2000
Clinical, pharmacokinetic, and pharmacodynamic effects of tolcapone withdrawal in levodopa-treated patients with parkinsonismK M Jorga, T L Davis, M C Kurth, et al.Pageof 2